{"columns": ["cmem_n_edit_distance", "cmem_n_is_updated", "cmem_n_memory_len", "cmem_n_memory_str", "cmem_n_memory_str_len"], "data": [[NaN, NaN, 7.0, "1. N0: No regional lymph node metastasis.\n2. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes in the absence of axillary lymph node metastasis.\n3. N2: Metastasis in 4-9 axillary lymph nodes or in clinically apparent ipsilateral internal mammary nodes in the presence of 1-3 axillary lymph node metastases.\n4. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral internal mammary lymph nodes in the presence of 4 or more axillary lymph node metastases, or in ipsilateral supraclavicular lymph nodes.\n5. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n6. Extracapsular extension is defined as the presence of tumor cells beyond the lymph node capsule.\n7. AJCC staging system for breast cancer uses the TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).", 913.0], [92.0, true, 8.0, "1. N0: No regional lymph node metastasis.\n2. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes in the absence of axillary lymph node metastasis.\n3. N2: Metastasis in 4-9 axillary lymph nodes or in clinically apparent ipsilateral internal mammary nodes in the presence of 1-3 axillary lymph node metastases.\n4. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral internal mammary lymph nodes in the presence of 4 or more axillary lymph node metastases, or in ipsilateral supraclavicular lymph nodes.\n5. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n6. Extracapsular extension is defined as the presence of tumor cells beyond the lymph node capsule.\n7. AJCC staging system for breast cancer uses the TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).\n8. N stage is based on the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.", 1069.0], [92.0, true, 8.0, "1. N0: No regional lymph node metastasis.\n2. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes in the absence of axillary lymph node metastasis.\n3. N2: Metastasis in 4-9 axillary lymph nodes or in clinically apparent ipsilateral internal mammary nodes in the presence of 1-3 axillary lymph node metastases.\n4. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral internal mammary lymph nodes in the presence of 4 or more axillary lymph node metastases, or in ipsilateral supraclavicular lymph nodes.\n5. N stage is determined by the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.\n6. Extracapsular extension is defined as the presence of tumor cells beyond the lymph node capsule.\n7. AJCC staging system for breast cancer uses the TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).\n8. The N stage is based on the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.", 1126.0], [95.0, true, 9.0, "1. N0: No regional lymph node metastasis.\n2. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes in the absence of axillary lymph node metastasis.\n3. N2: Metastasis in 4-9 axillary lymph nodes or in clinically apparent ipsilateral internal mammary nodes in the presence of 1-3 axillary lymph node metastases.\n4. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral internal mammary lymph nodes in the presence of 4 or more axillary lymph node metastases, or in ipsilateral supraclavicular lymph nodes.\n5. N stage is determined by the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.\n6. Extracapsular extension is defined as the presence of tumor cells beyond the lymph node capsule.\n7. AJCC staging system for breast cancer uses the TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).\n8. The N stage is based on the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.\n9. The N stage does not differentiate between internal mammary, inframammary, or ipsilateral internal mammary lymph nodes.", 1249.0], [96.0, true, 10.0, "1. N0: No regional lymph node metastasis.\n2. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes in the absence of axillary lymph node metastasis.\n3. N2: Metastasis in 4-9 axillary lymph nodes or in clinically apparent ipsilateral internal mammary nodes in the presence of 1-3 axillary lymph node metastases.\n4. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral internal mammary lymph nodes in the presence of 4 or more axillary lymph node metastases, or in ipsilateral supraclavicular lymph nodes.\n5. N stage is determined by the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.\n6. Extracapsular extension is defined as the presence of tumor cells beyond the lymph node capsule.\n7. AJCC staging system for breast cancer uses the TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).\n8. The N stage is based on the number of positive lymph nodes and the presence of extranodal extension, regardless of the total number of lymph nodes examined.\n9. The N stage does not differentiate between internal mammary, inframammary, or ipsilateral internal mammary lymph nodes.\n10. The N stage is determined by the number of positive lymph nodes, with or without extranodal extension.", 1356.0]]}